Withdrawal of inhaled nitric oxide from nonresponders after short exposure

Journal of Perinatology

Volumn 23, Issue 7, 2003, Pages 556-558

  Carriedo, Heather ^a   Rhine, William ^b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PLACEBO;

ACUTE RESPIRATORY FAILURE; ARTERIAL GAS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; NEWBORN HYPOXIA; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; TISSUE OXYGENATION; TREATMENT FAILURE;

ADMINISTRATION, INHALATION; DRUG RESISTANCE; HUMANS; INFANT, NEWBORN; NITRIC OXIDE; OXYGEN; RESPIRATORY INSUFFICIENCY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0242456055     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210980     Document Type: Review

References (15)

1. NINOS. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
2. Davidson D, Barefield ES, Kattwinkel J et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multi-center study. Pediatrics 1998;101:325-34.
3. Roberts JD, Fineman JR, Morin III FC et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336:605-10.
4. Mercier JC, Lacaze T, Storme L, Roze JC, Dinh-Xuan AT, Dehan M, the 'French Pediatric Study Group of Inhaled NO'. Disease related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. Eur J Pediatr 1998;157:742-57.
5. Cornfield DN, Maenad RC, deRegnier RO, Guiang III SF, Barbato JE, Milla CE. Randomized, controlled trial of low-dose inhaled nitric oxide treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics 1999;104:1089-94.
6. Davidson D, Barefield ES, Kattwinkel J et al. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics 1999;104:231-6.
7. Schulze-Neick I, Werner H, Penny DJ, Alex-Meskishvilli V, Lange PE. Acute ventilatory restriction in children after weaning off inhaled nitric oxide: relation to rebound pulmonary hypertension. Intens Care Med 1999;25:76-80.
8. Kinsella JP, Truog WE, Walsh WF et al. Randomized, multicenter trial of inhaled nitric oxide and high frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
9. Hoehn T, Krause M, Hentschel R. High frequency ventilation augments the effect of inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Eur Res J 1998;11:234-8.
10. Kinsella JP, Abman SH. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn. Eur J Pediatr 19981;57(1):S28-30.
11. Haddad IY, Ischiropoulos H, Holm BA. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993;265(6 Pt 1):L555-64.
12. Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, Fineman JR. Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol. 1998;274:L833-41.
13. Sheehy AM, Burson MA, Black SM. Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide. Am J Physiol 1999;277:H1849-56.
14. Horstman DJ, McCall D, Frank DU, Rich GF. Inhaled nitric oxide and nifedipine have similar effects on lung cGMP levels in rats. Anesth Analg 1999;89:932-7.
15. Yuhanna IS, MacRitchie AN, Lantin-Hermoso RL, Shaul PW. Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1999-,21:629-36.